Medical Treatment: Pain-Free Case - Essay Example

Pain free Case Study For years, surgical and other related treatment with relation to its rehabilitation has something to do with pain. In these cases, there are patients who refuse treatment because they have been afraid of pain that the treatment would induce into them and this prompted to set aside treatment and let themselves stumbled by a certain disease. However, there are arguments came into picture in prolonging the life of a certain individual only if they have chose to undergo treatment even though it is painful to carry. Since then, there are many programs and different types of treatment became available in to correct this notion and to encourage patients to submit themselves to treatment. However, we cannot deny the fact that no matter how these treatments claim their effectiveness, still, pain is the outmost concern not only of patients but also by the Doctors themselves. Because of pain, treatment is still a wall to destroy in order to fulfill and complete the treatment. There are a lot of instances wherein patients decline to continue their treatment because they cannot withstand pain. In this case, Doctors will have no option but to abide by the request of the patient because declining to be treated is also the right of the patient. Also, we cannot deny the fact that there are instances wherein patients die because of pain. In the same way there are also cases in which the patient's medical condition becomes worse and this occurrence was brought by the pain which is the main burden of the most of the patient encountering this situation. In the late 1989, a synthetic morphenomimetic through a name called nomoramide (commonly known as Painfree) was made and conceptualized by Chrysantheme Pharmaceutical Works. This breakthrough had set a new standard in terms of medical evolution of different medical treatment for reliving pain. Also, one can be assured that the aforementioned drug is safe due to its derivatives from natural herbs. With this, there are a lot of consumers that have become interested in purchasing the said product due to its effectiveness in relieving pain and it is more convenient to use. As per medical analysis is concerned, it is a breakthrough in the said practice being categorized as high potency, non-additive analgesic drug which can be taken orally. Having all these description, the said drug has gained its fame in the global pharmaceutical arena. However, there are still a lot of problems and controversies that surround the use of the said drug. Being categorized as synthetic morphenomimetic, it is very much difficult to use due to its side effects involving high toxic content. A medicine in the name of Tetramoramide, which is the same category of the Painfree drug, was waived by US due to reported deaths involving the use of the aforementioned drugs. Still, the rising fame of painfree had attracted different companies in Europe and other parts of the globe due to its effectiveness and high market potential. With this, a research group was made in order to further study the said drug and was licensed by Teutonia from CPW recognizing its market potential in the future. The pain free program as a whole proved to be successful in convincing and penetrating markets as well as building consortiums with other companies and this brings early popularity of the drug, even before its launch to the market. By having different connections not only to the entire Europe but to the rest of the world, it proved its marketability and it established its first-hand customers through the aforementioned premises. Also, relevant and collective studies to further assess the betterment of the drug as well as to find new ways on how to minimize if not eradicate the toxic side effects of the said drug being entered into such a classification. During these times, the pain free team doesn't rely on their knowledge as a group alone but also, they engaged into outsourcing, seeking the aid of expert panels and opinion leaders present in five countries were the pain free group had its preliminary studies. In analyzing such things, occurrences such as these helped pain free group to analyze more and make necessary adjustments for the drugs, its formulations, its market, formulations as well as contra-indications. With this, the pain free group has gathered the needed data in order to further improve the drug itself. In this case, the management of people particularly from the pain free group and the outsourced group has formed a certain project. This project aims to further know the potentials and the limitations of the drug in order to pursue its target penetration of market. Here, people involved in this project must have a synchronized and organized in order to attain their objective which is to know the potential and limitation of the drug in selected countries. In the aforementioned situation Project management is vital in order to attain the goal and be able to coordinate with fellow workers which are involved in the project. The term project management according to Maylor (1999) deals with efforts concerning voluminous allocation, consumption and utilization with the direction of resources (both human and technical) driven by time in lieu of individual efforts of people within the project from its conception until the delivery of the project along with the project's cost from the acquisition, to allocation up to consumption. This means that in order to fulfill projects, funding allocation is vital to satisfy the needs of the people and the requirement of the project per se. Also, the management of different resources of the project is an important factor here. In this case, management includes human resources. Also, the project deals with allocation, consumption and utilization of the people concerned of the needed. While fulfilling the project, people working on this must know their resources and they must adjust for whatever resources are possible. In the painfree's case, it was evident that their pilot saturation within five selected countries where they have their preliminary research regarding the aim of the project was clearly catered. This short-term objective is somewhat a success of the company as a whole if we are to deal with the company's success as a whole in realizing their pilot phases of the business strategy concerning the painfree drug. This kind of management was also discussed by Kezsborn 1989 stating that "Project management is the planning, organizing, directing, and controlling of company resources... for a relatively short-term objective. Having the aforementioned premise, one might conclude and suggests that painfree had its preliminary success even before its launching and even before it penetrates the market. With this, a group was formed solely to focus in the development of the said drug in order to assess its marketability as well as its effectiveness within the global market. The management also recognized that it should be treated as separate entity performing separate function with regards to its operation, perhaps, for the team to fully exercise their independence as well as to further explore the potential of the drug to the fullest minus the interest of the top-brass of the company. Upon looking into this situation, there is a huge possibility that the conception and introduction of the drug into the market along with its projected outcome would be realized to the fullest. With this, one can be assured that there are no rooms for the plan involving pain free to succumb with its staff having full-access to the company, equipment wise and its resources in general. However, we cannot deny the fact that these privileges would also be misused and abused by the people that are involved in this project. The aforementioned premises suggests the group's independence from the company and with this, the group has the luxury to make decisions, involve in deals, and the worst-case scenario is that the members would sabotage the study of the drug as well as a possible under-the-table agreement with other competing companies. One cannot deny its possibilities due to the fact that the group enjoys absolute independence towards the company. The success of the project if we are to base it on a short term basis was evident upon analyzing that from five countries that served as pilot areas for the study of the marketability and effectiveness of the product also paved the way to some problems as well. Of course, it was evident that in the short-term goal of painfree, the execution and the dissemination of the vital information, assessing the problems as well as the allocation of resources was made well. In such cases, the company has decided to expand its network after determining that the preliminary phase was successful involving the pilot batch and the core group of painfree. These instances paved the way for the group to tie-up with several more companies in which at that time was somehow evident that they do have vested interest with the said drug-Either the intent was to know the formulation of the drug or to at least jive with the popularity of the said company possessing the pain fee drug. The team then faced an uncertainty in facing risks to further advance the plans of the company. The idea of risk management now comes into picture. In this case, there are a lot of adjustments and things that are to be done. However, the team chose to expand its network solely on the basis of being successful in the preliminary phase. With this the formulation is somewhat affected and the drug was represented by a lot of companies which is somewhat unhealthy for a product to be introduced into market. Upon the conception of this thing, doctors now tend to weigh the effectiveness of the said drug regarding the saturated countries. It was known that the drug have its difference with its effectiveness on the basis that people from different parts of the world vary with the tolerance of their body in accordance with their environment. With this, there are a lot of reported side effects with the use of this drug. With this phenomenon, a lot of issues have been raised upon and this leads to problems concerning the Asian market particularly in China and in Europe. It was clear that the group failed to anticipate further limitations upon broadening their markets. With this, issues concerning public health as well as the partition of sales brought malady into the companies that were involved sharing the prestige of the drugs. Because of medical concerns, it was believed that the remaining phases in the conceptualization failed due to the controversies surrounding the products market. Also, due to the fact that there are different companies that are now associated with the drug, there are a variety of explanations and interpretations regarding the status of the product with regards to catering its target users as well as its profitability in the market. These premises creates a more confusing scenario on what concerns must be addressed first or to be regarded with outmost priority Also, cases that were filled on courts concerning the use of the said drugs added insult to the injury which was not anticipated by the painfree group beforehand. With this, misunderstandings rose up and this further added on deconstructing the image of the product particularly on courts which is the main reason why courts have ordered to restrict the drug particularly in the European market. With this, the realization of the remaining phases with regards to marketing of the product has turned into vain, nullifying the previous efforts that have been made by the first company and the painfree group in marketing the drug. If given the chance to rectify the wrongs that have been done, lets say the company is about to introduce another drug, I would prefer to analyze things that are to be done in merging with other companies, check their backgrounds as well. Also, the saying great power also has great responsibility applies to this premise. The fact the company has tried to make ties with other companies using this new drug, the analysis of the background of the company. Also, before introducing and penetrating the market with a new product, it needs to have a thorough research analysis from the people who invented and conceptualize it before outsourcing and clinging in with outsiders to prevent the product's identity to be withheld and to further prevent the other companies from obtaining necessary information concerning the use and potential market of the product. Also, it is very important to know the specific market that the drug caters. With this, the company would be assured that the identity of the drug that are to be launched is protected. Having these preventive measures, the assurance of launching a new medical product sans the hassle of introducing it to the market on a projected time table would be observed. Reference: 1) Maylor Harvey., Project Management. Prentice Hall (3rd ed.) 2003. ISBN 0-273-70431-1 2)Deborah Kezsbom, et al., Dynamic Project Management. John Wiley & Sons, 1989. With notes from Turner J R., The Handbook of Project Based Management (2nd ed.) McGraw Hill. 1999. Ward S and Chapman C., Managing Project Risk and Uncertainty. J Wiley & Sons. 2002. Read More